CHOP's breakthrough cancer immunotherapy program receives generous grant from the Emily Whitehead Foundation
The Children's Hospital of Philadelphia News | Apr 20, 2018
FDA approves nivolumab/ipilimumab combination for intermediate- or poor-risk advanced RCC
European Society for Medical Oncology News | Apr 20, 2018
Dual inhibition of IDO1 and PD-L1 safe in patients with advanced solid tumors
American Association for Cancer Research News | Apr 20, 2018
Early skin cancer more accurately diagnosed by dermatologist
UPMC News | Apr 20, 2018
Sedentary lifestyle drastically increases risk of dying from cancer
Roswell Park Cancer Institute News | Apr 20, 2018
Cancer therapy: An interaction map of genes shows the best targets
German Cancer Research Center News | Apr 20, 2018
Structure of key developmental enzyme complex revealed
UT Southwestern Medical Center | Apr 20, 2018
A drug used in metabolic diseases is effective in the treatment of resistant testicular cancer tumors
IDIBELL-Bellvitge Biomedical Research Institute News | Apr 20, 2018
Protein associated with aggressive breast cancer
UT Southwestern Medical Center | Apr 20, 2018
Roswell Park researchers identify epigenetic changes that may help explain racial disparities in breast cancer
Roswell Park Cancer Institute News | Apr 20, 2018